Stockscreener 앱 받기
171.75
1.24%
2.10
시장 영업 전:
170.61
-1.14
-0.66%
전일 마감가:
$169.65
열려 있는:
$168.89
하루 거래량:
1.42M
Relative Volume:
1.59
시가총액:
$19.00B
수익:
$9.54B
순이익/손실:
$841.00M
주가수익비율:
23.08
EPS:
7.44
순현금흐름:
$1.02B
1주 성능:
+4.50%
1개월 성능:
+13.59%
6개월 성능:
+13.65%
1년 성능:
+38.51%
1일 변동 폭
$168.78
$172.64
1주일 범위
$164.61
$172.64
52주 변동 폭
$123.30
$172.64
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
171.75 | 19.00B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
530.86 | 203.05B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
204.98 | 147.40B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
137.15 | 39.13B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
450.99 | 36.93B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
196.51 | 34.61B | 15.41B | 1.37B | 2.11B | 7.50 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Van ECK Associates Corp - MarketBeat
Vontobel Holding Ltd. Has $7.14 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
New York State Teachers Retirement System Cuts Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.
Quest Diagnostics stock hits 52-week high at $171.42 By Investing.com - Investing.com Nigeria
Quest Diagnostics stock hits 52-week high at $171.42 - Investing.com
Quest Diagnostics Incorporated (NYSE:DGX) Shares Bought by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Is There An Opportunity With Quest Diagnostics Incorporated's (NYSE:DGX) 50% Undervaluation? - Yahoo Finance UK
Rhumbline Advisers Sells 8,647 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Empowered Funds LLC - MarketBeat
MOKAN Wealth Management Inc. Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Sheaff Brock Investment Advisors LLC Makes New Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
How Is Quest Diagnostics' Stock Performance Compared to Other Diagnostics & Research Stocks? - MSN
Earnings Preview: What to Expect From Quest Diagnostics' Report - MSN
Chevy Chase Trust Holdings LLC Purchases 11,821 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics (NYSE:DGX) Sets New 12-Month HighHere's What Happened - MarketBeat
Palumbo Wealth Management LLC Acquires 2,396 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
State of Alaska Department of Revenue Trims Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
WCM Investment Management LLC Acquires 1,647 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Grail shares jump on partnership with Quest Diagnostics - Mugglehead
SVP for Diagnostic Services Plewman Patrick was granted 2,042 shares, increasing direct ownership by 12% to 18,402 units (SEC Form 4) - Quantisnow
Avestar Capital LLC Cuts Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Weatherly Asset Management L. P. Sells 2,930 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Cambiar Investors LLC Sells 9,196 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Savant Capital LLC Has $1.80 Million Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Yousif Capital Management LLC Has $2.77 Million Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Unveils Future Roadmap: Lab Market Strategy and Growth Plans Take Center Stage - StockTitan
Grail rallies 30% in wake of Quest agreement (GRAL:NASDAQ) - Seeking Alpha
Grail and Quest Diagnostics to offer Galleri test to US physicians - Medical Device Network
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Grail Shares Spiked Wednesday: What's Going On? - Benzinga
Kentucky Trust Co Buys Shares of 1,506 Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Argus Adjusts Price Target on Quest Diagnostics to $185 From $175, Maintains Buy Rating - Marketscreener.com
Grail And Quest Diagnostics Provide Grail's Galleri Multi-Cancer Early Detection (MCED) Test - Marketscreener.com
Revolutionary Cancer Detection Test Now Available at Quest Labs NationwideEarly Detection for 50+ Types - StockTitan
Self-Testing Market Projected To Witness Substantial Growth, 2025-2032:Quest Diagnostics, Bionime Corporation, - EIN News
Quest Diagnostics Incorporated (NYSE:DGX) SVP Mark E. Delaney Sells 403 Shares - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Director Sells $205,712.50 in Stock - MarketBeat
GHP Investment Advisors Inc. Boosts Stake in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term - Nasdaq
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats - Nasdaq
Quest Diagnostics (NYSE:DGX) Stock Rating Lowered by StockNews.com - MarketBeat
YANKCOM Partnership Takes $1.07 Million Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Martin Capital Partners LLC - MarketBeat
Jericho Financial LLP Makes New $590,000 Investment in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
자본화:
|
볼륨(24시간):